Fibroid

4

Review clinical trials related to Fibroid. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Prescription of Letrozole for Uterine Myoma

The PLUM Study is a randomized, double-blinded, 2-arm, parallel-group, placebo-controlled trial is designed to compare the efficacy of letrozole versus placebo on leiomyoma-related symptoms and quality of life as well as leiomyoma and uterine size.

Participants needed: 140
Trial details
Phase: Phase 4Age: 21-53Biological sex: FemaleType: InterventionalSponsor: University of California, San FranciscoUpdated: Jun 10, 2026Locations: 5
Eligibility criteria

At least 21 and less than 54 years of age (to focus on an adult, premenopausal p... [+6]

Screening pelvic imaging indicating any leiomyomata ≥10 cm in maximum diameter,... [+20]

Status: Recruiting

Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)

The investigators are evaluating the role of senescent cells in uterine fibroids.

Participants needed: 150
Trial details
Age: 18-55Biological sex: FemaleType: ObservationalSponsor: Johns Hopkins UniversityUpdated: Dec 11, 2025Locations: 1
Eligibility criteria

Subjects must be women above the age of ≥18 - ≤55 years. [+3]

Unwilling to sign the consent form or complete questionnaire. [+2]

Status: Recruiting

Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology

GynRAN is an international, multicentre, transversal, diagnostic and non-interventional study carried out in gynecology-obstetrics/gynecological oncology departments that aims to identify a diagnostic signature for gynecological pathologies by analyzing of coding and non-coding RNA contained in patients saliva. The study population consists of patients with clinically symptomatic females with one or more of the gynecological pathologies (endometriosis, adenomyosis, ovarian cysts, fibroids, ovarian/cervical/uterine cancer) and asymptomatic females. The patients concerned by the study will be managed without modification of the care pathway, nor modification of the therapeutic indications, nor modification of the diagnostic or follow-up examinations necessary according to the context, which are carried out according to the local recommendations.

Participants needed: 2,500
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: ZIWIGUpdated: Jan 23, 2025Locations: 13
Eligibility criteria

Subject of legal age (according to local legislation) and at least 18 years old [+11]

Recent (<1 month) or ongoing bacterial or viral infection [+10]

Status: Not yet recruiting

Evaluation of Ultrasound-guided Transuterine Vaginal Biopsy Technique in Uterine Fibromatous Disease

The goal of this diagnostic, prospective study is to evaluate an innovative, minimally invasive surgical technique for diagnosing uterine smooth muscle tumors by biopsy, in women aged 18 and more, and to evaluate complications relating to the the technique and its potential adverse events. Participants presenting at hospital patients presenting a surgical indication for myomectomy or hysterectomy during the inclusion period will be offered the study. Preoperatively, women will undergo the following two examinations: 1. A pelvic MRI, the characteristics of which will be analyzed by the expert women\&#39;s imaging team. 2. A BVTE under general anaesthetic in the operating theatre on the day of the planned myomectomy or hysterectomy. 250 women will be included in this study within a periofd of inclusion of 36 months and their participation is estimated to 7 months Total study duration is 43 months

Participants needed: 250
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Assistance Publique Hopitaux De MarseilleUpdated: Aug 30, 2024
Eligibility criteria

Patients over 18 years of age consulting at the hospital who require surgical ma... [+2]

Person in a period of exclusion from another research protocol at the time conse... [+7]